SourceOne Healthcare Technologies, Inc. Renews Distribution Agreement with iCAD, Inc.

Share Article

Sales success coupled with a tremendous distribution channel result in two-year agreement extension.

SourceOne Healthcare Technologies, Inc., one of the nation’s leading distributors of medical imaging systems, equipment, radiographic consumable supplies, and service to healthcare providers, and iCAD, Inc., an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the companies have signed an extended two-year national distribution agreement.

Under terms of the agreement, SourceOne will continue to distribute iCAD’s Second Look® film-based mammography CAD systems in the United States. The Second Look systems are compatible with all digital and film-based mammography systems. Since October of 2003, SourceOne has sold iCAD as it’s only offering in the CAD category and has shipped more than 100 Second Look systems. Together, both companies are making CAD technology more accessible to hospitals, imaging centers and women’s health centers nationwide.

"SourceOne has been a vital link for the distribution of iCAD Second Look systems to customers throughout the country," said Scott Parr, president and CEO of iCAD, Inc. "We are pleased to renew our partnership and look forward to working together to help women gain broader access to our proven early breast cancer detection technology."

"We are committed to providing our customers the latest technology to improve women’s health, such as CAD, mammography, mammography information systems, diagnostic digital and analog systems and supplies," said Jerry C. Cirino, SourceOne president and CEO. "iCAD’s Second Look CAD systems lead the industry in helping physicians battle the war against breast cancer. We are proud to be able to continue to offer our customers the number one rated CAD solution."

Repeatedly recognized as offering "The Winning Combination" of Price and Performance by MD Buyline, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD’s Second Look systems act very much like a second pair of eyes, assisting doctors in detecting up to 68 percent of actionable missed breast cancers an average of 15 months earlier than screening mammography alone.

About SourceOne Healthcare Technologies, Inc.

Headquartered in Mentor, Ohio, SourceOne Healthcare Technologies is a leading provider of imaging equipment, radiographic supplies and services tailored to healthcare facilities including those transitioning to a digital imaging environment. Its broad equipment and consumables lines, e-logistics, sales professionals and field service engineers enable customers to turn to SourceOne as the best-in-class, single source for effective supply chain and medical imaging management. SourceOne is a privately held company of Platinum Equity, a global acquisitions firm specializing in the strategic operation of mission-critical companies. For additional information about SourceOne, visit http://www.sourceonehealth.com.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan’s Growth Strategy Leadership award and repeatedly recognized as offering “The Winning Combination” of Price and Performance by MD Buyline, iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. As the most frequently selected CAD solution for film-based and digital breast screening, iCAD is entrusted with the task of early cancer detection by almost one thousand women’s healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company’s other filings with the Securities and Exchange Commission. The words "believe",

"demonstrate", "intend", "expect", "estimate",

"anticipate", "likely", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.

Contacts:

Jennifer Barnwell

Marketing Communications Manager

SourceOne Healthcare Technologies, Inc.

440.701.1200

http://www.sourceonehealth.com

Todd E. Appleman

The Appleman Group

323.850.7664

Kevin McGrath

iCAD Investor Relations

Cameron Associates

212.245.4577

Monica Pandolfi

iCAD Media Relations

SHIFT Communications

617.681.1235

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Todd Appleman